Patent · US Active

MCP-1 binding nucleic acids and use thereof

US8367629B2 · kind B2 · utility

3Cited by

4References

14Claims

0Family size

Assignee

NOXXON Pharma AG · DE

Inventors

Werner Purschke · Berlin, DE
Florian Jarosch · Berlin, DE
Dirk Eulberg · Berlin, DE
Sven Klussmann · Berlin, DE
Klaus Buchner · Schaffhausen, CH
Christian Maasch · Berlin, DE

Key dates

Filing date	Nov 29, 2008
Grant date	Feb 5, 2013
Priority date	—
Expiry date	Apr 12, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to a nucleic acid molecule capable of binding to MCP-1, whereby the nucleic acid molecule is for use as a medicament for the treatment and/or prevention of a chronic disease or chronic disorder, preferably selected from the group consisting of chronic respiratory disease, chronic kidney disease and systemic lupus erythematosus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.